Experience with hemoadsorption (CytoSorb ® ) in the management of septic shock patients.

CytoSorb is a safe and well tolerated rescue therapy option in patients with septic shock. However, early (preferably within < 48 h after onset of septic shock) initiation could result in better clinical outcomes. Further randomized trials are needed to define the potential benefits of this new treatment modality.